EUVIMEDEUVIMED entdecken
Crossref

Polymorphism in the Drug Transporter Gene ABCB1 as a Potential Disease Modifier in Cortisol-Producing Adrenal Adenomas

Frederick Vogel iD, Leah Braun, Sharmilee Vetrivel, Ru Zhang, Stephanie Zopp, Andrea Oßwald, Elisabeth Nowak, Katharina Schilbach, Martin Bidlingmaier, Petra Zimmermann iD, Felix Beuschlein, Michaela Hartmann und 3 weitere

Experimental and Clinical Endocrinology & Diabetes · 01.11.2024 · 132 (11) · 608-613

DOI: 10.1055/a-2408-0718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.11.2024. Verfasst von Frederick Vogel und 14 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universitat Munchen, Munich, Germany. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily B, Hydrocortisone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Else Kröner-Fresenius-Stiftung, Deutsche Forschungsgemeinschaft, Munich Clinician Scientist Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Endogenous hypercortisolism presents with variable phenotypes. Etiological factors accounting for the level of hypercortisolism or varying severity of associated comorbidities are lacking. Recently, the adrenal ATP-binding cassette B1 (ABCB1) gene was identified as a modulator of glucocorticoid secretion.

Objective

To evaluate the effect of ABCB1 polymorphism rs2032582 on steroid metabolome and clinical phenotypes in patients with endogenous hypercortisolism.

Methods

In this cross-sectional cohort study, 137 patients prospectively enrolled in the German Cushing’s registry were included (41 with ACTH-producing pituitary adenoma, 21 with cortisol-producing adrenal adenoma, and 75 with excluded hypercortisolism). In all patients, ABCB1 polymorphism was analyzed using a TaqMan genotyping assay, glucocorticoid metabolite excretion in 24-hour urine samples was analyzed by gas chromatography-mass spectrometry, and the clinical phenotype was assessed systematically.

Results

In patients with cortisol-producing adrenal adenomas, but not in patients with ACTH-producing pituitary adenomas, homozygous major allele GG of ABCB1 polymorphism rs2032582 was associated with higher overall cortisol metabolite secretion (median 13515 [IQR 10347; 25669] µg/24h vs. 9645 [6146; 10732] µg/24h in minor homo- and heterozygotes, p=0.036) and elevated major cortisol metabolites αTHF, THF and THE (9339 [6929; 17789] µg/24h vs. 6288 [4184; 7455] µg/24h, p=0.045). Moreover, these patients showed higher mean arterial pressure (116 [111; 131] mmHg in major homozygotes vs. 105 [96; 112] mmHg in minor homo- and heterozygotes, p=0.036).

Conclusion

The genotype of drug transporter gene ABCB1 rs2032582 polymorphism is associated with the degree of cortisol metabolite secretion in cortisol-producing adrenal adenomas and could, therefore, represent a modifier of disease severity in this context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ATP Binding Cassette Transporter, Subfamily BHydrocortisoneHumansMaleFemaleMiddle AgedAdultCross-Sectional StudiesAdrenocortical AdenomaPolymorphism, Single NucleotideAdrenal Gland NeoplasmsAdenomaAgedCohort Studies

Substanzen

ABCB1 protein, humanATP Binding Cassette Transporter, Subfamily BHydrocortisone

Autor:innen und Institutionen

  • Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-Universitat Munchen, Munich, Germany.
  • Deggendorf Institute of Technology, Deggendorf, Germany.
  • Department of General, Visceral and Transplantation Surgery, LMU University Hospital, Ludwig Maximilian University of Munich, München, Germany.
  • Klinik für Endokrinologie, Diabetologie und Klinischer Ernährung, UniversitätsSpital Zürich, Zurich, Switzerland.
  • The LOOP Zurich - Medical Research Center, Zurich, Switzerland.
  • Paediatric Endocrinology & Diabetology, Justus Liebig University Giessen, Center of Child and Adolescent Medicine, Giessen, Germany.

ORCID-Profile: Frederick Vogel, Petra Zimmermann

Förderung

  • Else Kröner-Fresenius-Stiftung
  • Deutsche Forschungsgemeinschaft
  • Munich Clinician Scientist Program
  • Clinician Scientist Program RISE

Zitieren

APA

Vogel, F., Braun, L., Vetrivel, S., Zhang, R., Zopp, S., Oßwald, A., Nowak, E., Schilbach, K., Bidlingmaier, M., Zimmermann, P., Beuschlein, F., Hartmann, M., Wudy, S., Riester, A., & Reincke, M. (2024). Polymorphism in the Drug Transporter Gene ABCB1 as a Potential Disease Modifier in Cortisol-Producing Adrenal Adenomas. Experimental and Clinical Endocrinology & Diabetes, 132(11), 608-613. https://doi.org/10.1055/a-2408-0718

Vancouver

Vogel F, Braun L, Vetrivel S, Zhang R, Zopp S, Oßwald A, et al. Polymorphism in the Drug Transporter Gene ABCB1 as a Potential Disease Modifier in Cortisol-Producing Adrenal Adenomas. Experimental and Clinical Endocrinology & Diabetes. 2024;132(11):608-613. doi:10.1055/a-2408-0718

BibTeX
@article{Vogel2024,
  author = {Vogel, Frederick and Braun, Leah and Vetrivel, Sharmilee and Zhang, Ru and Zopp, Stephanie and Oßwald, Andrea and Nowak, Elisabeth and Schilbach, Katharina and Bidlingmaier, Martin and Zimmermann, Petra and Beuschlein, Felix and Hartmann, Michaela and Wudy, Stefan and Riester, Anna and Reincke, Martin},
  title = {Polymorphism in the Drug Transporter Gene ABCB1 as a Potential Disease Modifier in Cortisol-Producing Adrenal Adenomas},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2024},
  volume = {132},
  number = {11},
  pages = {608--613},
  doi = {10.1055/a-2408-0718}
}
Kostenlos starten →